Cargando…

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls

OBJECTIVE: The interleukin-8 (IL-8) has been reported to play an important role in depression, which might be modulated by the selective serotonin reuptake inhibitors (SSRIs). Thus, the aim of this study was to investigate serum IL-8 levels, depressive symptom, and their associations in drug-free MD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhen Hua, Song, Xiao Ying, Man, Li Juan, Chen, Peng, Tang, Zhen, Li, Rong Hua, Ji, Cai Fang, Dai, Ning Bin, Liu, Fang, Wang, Jing, Zhang, Jianping, Jia, Qiu Fang, Hui, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046727/ https://www.ncbi.nlm.nih.gov/pubmed/35492731 http://dx.doi.org/10.3389/fpsyt.2022.858675

Ejemplares similares

Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs
por: Cai, Yuan, et al.
Publicado: (2023)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

Factors that contribute to trait mindfulness level among hospitalized patients with major depressive disorder
por: Ji, Cai-Fang, et al.
Publicado: (2023)

Changes in Regional Homogeneity of Medication-Free Major Depressive Disorder Patients With Different Onset Ages
por: Zhang, Zijian, et al.
Publicado: (2021)

Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia
por: Yin, Xu Yuan, et al.
Publicado: (2022)

Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study
por: Li, Xueqin, et al.
Publicado: (2023)

Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls
por: Shi, Jing, et al.
Publicado: (2022)

Neural activity in adults with major depressive disorder differs from that in healthy individuals: A resting-state functional magnetic resonance imaging study
por: Hou, Xiaofang, et al.
Publicado: (2022)

Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in China
por: Liu, Zhi-Sheng, et al.
Publicado: (2020)

A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs
por: Zhang, Yifan, et al.
Publicado: (2015)

The Influence of Family-Related Factors on Suicide in Major Depression Patients
por: Wang, Wei, et al.
Publicado: (2022)

Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010)

Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression
por: Yang, Hao, et al.
Publicado: (2022)

Resveratrol supplementation enhanced SSRIs efficacy in premenopausal women with major depressive disorder
por: Fedotova, J., et al.
Publicado: (2023)

Efficacy and safety of intermittent theta burst stimulation versus high-frequency repetitive transcranial magnetic stimulation for patients with treatment-resistant depression: a systematic review
por: Lan, Xian-Jun, et al.
Publicado: (2023)

Detection of Schizophrenia Cases From Healthy Controls With Combination of Neurocognitive and Electrophysiological Features
por: Tian, Qing, et al.
Publicado: (2022)

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
por: Zhang, Aixia, et al.
Publicado: (2022)

Altered Local Gyrification Index and Corresponding Functional Connectivity in Medication Free Major Depressive Disorder
por: Long, Jiang, et al.
Publicado: (2020)

Vortioxetine Modulates the Regional Signal in First-Episode Drug-Free Major Depressive Disorder at Rest
por: Xiong, Shihong, et al.
Publicado: (2022)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Wang, Xue-Qin, et al.
Publicado: (2021)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
por: Sun, Xiao-Li, et al.
Publicado: (2023)

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report
por: Park, Young-Min, et al.
Publicado: (2012)

Effect of SSRIs on Resting-State Functional Brain Networks in Adolescents with Major Depressive Disorder
por: Chu, Shu-Hsien, et al.
Publicado: (2021)

Interleukin-8 and tumor necrosis factor-alpha in youth with mood disorders—A longitudinal study
por: Skibinska, Maria, et al.
Publicado: (2022)

Neurological Soft Signs (NSS) in Census-Based, Decade-Adjusted Healthy Adults, 20 to >70 Years of Age
por: Bachmann, Silke, et al.
Publicado: (2021)

Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011)

Continuing medical education: SSRIs and pregnancy
por: Andrade, Chittaranjan
Publicado: (2010)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

Lifestyle and Social Factors Exacerbated on the Prevalence of Mood Disorders and Functional Dyspepsia Among Neonatal Nurses in China
por: Huang, Zhen-peng, et al.
Publicado: (2022)

Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2021)

Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month
por: Chen, Ke-Yang, et al.
Publicado: (2020)

Perceived Social Support and Associated Factors Among Community-Dwelling Older Adults With Frailty and Pre-frailty in Hangzhou, China
por: Fang, Juan, et al.
Publicado: (2022)

Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia
por: An, Ji Hyun, et al.
Publicado: (2020)

Chronic Stress Disturbs Metabolome of Blood Plasma and Urine in Diabetic Rats
por: Ren, Yu, et al.
Publicado: (2018)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

Association of Lipid Profile and Suicide Attempts in a Large Sample of First Episode Drug-Naive Patients With Major Depressive Disorder
por: Ma, Yue-Jiao, et al.
Publicado: (2020)

Psychometric Evaluation of the Major Depression Inventory (MDI) as a Depression Severity Scale in Chinese Patients With Coronary Artery Disease. Findings From the MEDEA FAR-EAST Study.
por: Chen, Yixiao, et al.
Publicado: (2019)

Deficits in odor discrimination versus odor identification in patients with schizophrenia and negative correlations with GABAergic and DNA methyltransferase mRNAs in lymphocytes
por: Smith, Robert C., et al.
Publicado: (2023)

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pr33fr174rn6ejb8do54kn5p13